(2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-iodobenzyl)pyrrolidine-2-carboxylic acid
98%
- Product Code: 235104
CAS:
959580-93-9
Molecular Weight: | 431.27 g./mol | Molecular Formula: | C₁₇H₂₂INO₄ |
---|---|---|---|
EC Number: | MDL Number: | MFCD06659438 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other bioactive molecules. Its structure allows for selective modifications at multiple functional sites, making it valuable in medicinal chemistry for constructing complex drug candidates. The presence of the iodobenzyl group facilitates coupling reactions, such as Suzuki or Heck reactions, enabling the introduction of aromatic moieties important for target binding. The Boc-protected amine and carboxylic acid groups permit stepwise deprotection and conjugation, supporting solid-phase or solution-phase peptide-like synthesis. Commonly employed in research settings for generating libraries of compounds in drug discovery programs.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
50mg | 10-20 days | ฿715.00 |
+
-
|
250mg | 10-20 days | ฿3,349.50 |
+
-
|
(2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-iodobenzyl)pyrrolidine-2-carboxylic acid
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other bioactive molecules. Its structure allows for selective modifications at multiple functional sites, making it valuable in medicinal chemistry for constructing complex drug candidates. The presence of the iodobenzyl group facilitates coupling reactions, such as Suzuki or Heck reactions, enabling the introduction of aromatic moieties important for target binding. The Boc-protected amine and carboxylic acid groups permit stepwise deprotection and conjugation, supporting solid-phase or solution-phase peptide-like synthesis. Commonly employed in research settings for generating libraries of compounds in drug discovery programs.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :